搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Oryza nivara 50S ribosomal protein L16, chloroplastic (rpl16) CSB-YP738612OCN
CSB-EP738612OCN
CSB-BP738612OCN
CSB-MP738612OCN
CSB-EP738612OCN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza nivara Cytochrome b6 (petB), partial CSB-YP738613OCN1
CSB-EP738613OCN1
CSB-BP738613OCN1
CSB-MP738613OCN1
CSB-EP738613OCN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza nivara Photosystem I reaction center subunit IX (psaJ), partial CSB-YP738614OCN
CSB-EP738614OCN
CSB-BP738614OCN
CSB-MP738614OCN
CSB-EP738614OCN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza nivara Apocytochrome f (petA), partial CSB-YP738615OCN1
CSB-EP738615OCN1
CSB-BP738615OCN1
CSB-MP738615OCN1
CSB-EP738615OCN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza nivara NAD (P)H-quinone oxidoreductase subunit K, chloroplastic (ndhK) CSB-YP738616OCN
CSB-EP738616OCN
CSB-BP738616OCN
CSB-MP738616OCN
CSB-EP738616OCN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza nivara ATP synthase subunit b, chloroplastic (atpF), partial CSB-YP738617OCN1
CSB-EP738617OCN1
CSB-BP738617OCN1
CSB-MP738617OCN1
CSB-EP738617OCN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza nivara Photosystem II reaction center protein M (psbM), partial CSB-YP738618OCN
CSB-EP738618OCN
CSB-BP738618OCN
CSB-MP738618OCN
CSB-EP738618OCN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza nivara Photosystem Q (B) protein (psbA), partial CSB-YP738619OCN1
CSB-EP738619OCN1
CSB-BP738619OCN1
CSB-MP738619OCN1
CSB-EP738619OCN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum officinarum 50S ribosomal protein L32, chloroplastic (rpl32) CSB-YP738620SVV
CSB-EP738620SVV
CSB-BP738620SVV
CSB-MP738620SVV
CSB-EP738620SVV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum officinarum Uncharacterized protein ycf73 (ycf73-A) CSB-YP738621SVV
CSB-EP738621SVV
CSB-BP738621SVV
CSB-MP738621SVV
CSB-EP738621SVV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum officinarum 30S ribosomal protein S8, chloroplastic (rps8) CSB-YP738622SVV
CSB-EP738622SVV
CSB-BP738622SVV
CSB-MP738622SVV
CSB-EP738622SVV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum officinarum Protein psbN (psbN), partial CSB-YP738623SVV
CSB-EP738623SVV
CSB-BP738623SVV
CSB-MP738623SVV
CSB-EP738623SVV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum officinarum Photosystem I reaction center subunit IX (psaJ), partial CSB-YP738624SVV
CSB-EP738624SVV
CSB-BP738624SVV
CSB-MP738624SVV
CSB-EP738624SVV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum officinarum Chloroplast envelope membrane protein (cemA), partial CSB-YP738625SVV1
CSB-EP738625SVV1
CSB-BP738625SVV1
CSB-MP738625SVV1
CSB-EP738625SVV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum officinarum NAD (P)H-quinone oxidoreductase subunit J, chloroplastic (ndhJ) CSB-YP738626SVV
CSB-EP738626SVV
CSB-BP738626SVV
CSB-MP738626SVV
CSB-EP738626SVV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum officinarum ATP synthase subunit c, chloroplastic (atpH), partial CSB-YP738627SVV1
CSB-EP738627SVV1
CSB-BP738627SVV1
CSB-MP738627SVV1
CSB-EP738627SVV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharum officinarum Uncharacterized protein ycf70 (orf81) CSB-YP738628SVV
CSB-EP738628SVV
CSB-BP738628SVV
CSB-MP738628SVV
CSB-EP738628SVV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Rac-like GTP-binding protein 5 (RAC5) CSB-YP738629OFG
CSB-EP738629OFG
CSB-BP738629OFG
CSB-MP738629OFG
CSB-EP738629OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable NADH kinase (Os09g0345700, LOC_Os09g17680) CSB-YP738630OFG
CSB-EP738630OFG
CSB-BP738630OFG
CSB-MP738630OFG
CSB-EP738630OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable cinnamyl alcohol dehydrogenase 8C (CAD8C) CSB-YP738631OFG
CSB-EP738631OFG
CSB-BP738631OFG
CSB-MP738631OFG
CSB-EP738631OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>